Inventor · disambiguated record
Jeffrey Allan Miller
Also filed as: MILLER JEFFREY A · MILLER JEFFREY ALLAN
17 granted patents·4 pending applications·211 citations·filing 1984–2023
93Inventor score
Files withWELLSTAT IMMUNOTHERAPEUTICS LLC4BRISTOL MYERS SQUIBB PHARMA CO3DEFINED DIAGNOSTICS LLC3DU PONT3WELLSTAT BIOLOGICS CORP3
Top patents by PatentIndex Score
21 records- 0193US5374524ASolution sandwich hybridization, capture and detection of amplified nucleic acidsDU PONT·Filed 1993·Granted Dec 20, 1994·120 cites·1 claims
- 0290US7122182B2Oncolytic virus therapyWELLSTAT BIOLOGICS CORP·Filed 2002·Granted Oct 17, 2006·25 cites·15 claims
- 0380US7914979B2Stable and filterable enveloped virus formulationsWELLSTAT BIOLOGICS CORP·Filed 2005·Granted Mar 29, 2011·9 cites·21 claims
- 0479US10415026B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2016·Granted Sep 17, 2019·2 cites·18 claims
- 0578US9533028B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2015·Granted Jan 3, 2017·2 cites·17 claims
- 0678US7223834B2Assays and peptide substrate for determining aggrecan degrading metallo protease activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2001·Granted May 29, 2007·3 cites·24 claims
- 0776US9228003B2Complement factor B analogs and their usesCHEN CHANGHUNG·Filed 2012·Granted Jan 5, 2016·4 cites·15 claims
- 0876US8137663B2Oncolytic virus therapyGROENE WILLIAM S·Filed 2009·Granted Mar 20, 2012·2 cites·24 claims
- 0976US7595042B2Oncolytic virus therapyWELLSTAT BIOLOGICS CORP·Filed 2005·Granted Sep 29, 2009·3 cites·15 claims
- 1076US2024310386A1Antibodies and methods for the detection of cell deathPHARMA CINQ LLC·Filed 2023·Application pending·0 cites
- 1172US11001822B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2020·Granted May 11, 2021·0 cites·23 claims
- 1272US10689637B2Complement factor B analogs and their usesWELLSTAT IMMUNOTHERAPEUTICS LLC·Filed 2019·Granted Jun 23, 2020·0 cites·16 claims
- 1368US6326162B1Assays and peptide substrate for determining aggrecan degrading metallo protease activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 1998·Granted Dec 4, 2001·14 cites·2 claims
- 1468US4670379APolynucleotide hydridization assays employing catalyzed luminescenceDU PONT·Filed 1984·Granted Jun 2, 1987·20 cites·16 claims
- 1565US2022065873A1Antibodies and Methods for the Detection of Cell DeathDEFINED DIAGNOSTICS LLC·Filed 2021·Application pending·0 cites
- 1662US11175295B2Antibodies and methods for the detection of cell deathDEFINED DIAGNOSTICS LLC·Filed 2019·Granted Nov 16, 2021·0 cites·8 claims
- 1757US2007238136A1Assays and peptide substrate for determining aggrecan degrading metallo protease activityBRISTOL MYERS SQUIBB PHARMA CO·Filed 2007·Application pending·0 cites
- 1857US2024299434A1Uridine triacetate amorphous formulationPHARMA CINQ LLC·Filed 2022·Application pending·0 cites
- 1952US10401368B2Antibodies and methods for the detection of cell deathPDL BIOPHARMA INC·Filed 2015·Granted Sep 3, 2019·0 cites·42 claims
- 2045US11054430B2Compounds and methods for the detection of methotrexateDEFINED DIAGNOSTICS LLC·Filed 2016·Granted Jul 6, 2021·0 cites·12 claims
- 2133US5726012ARapid, high capacity nucleic acid based assayDU PONT·Filed 1994·Granted Mar 10, 1998·7 cites·14 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →